These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34120187)

  • 1. A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling.
    Goldberg R; Clough JN; Roberts LB; Sanchez J; Kordasti S; Petrov N; Hertweck A; Lorenc A; Jackson I; Tasker S; Appios A; Omer O; Parkes M; Prescott N; Jenner RG; Irving PM; Lord GM
    J Crohns Colitis; 2021 Dec; 15(12):2054-2065. PubMed ID: 34120187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
    Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
    Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells.
    Sewgobind VD; Quaedackers ME; van der Laan LJ; Kraaijeveld R; Korevaar SS; Chan G; Weimar W; Baan CC
    Am J Transplant; 2010 Aug; 10(8):1785-95. PubMed ID: 20626385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
    Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
    Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.
    Garg G; Tyler JR; Yang JH; Cutler AJ; Downes K; Pekalski M; Bell GL; Nutland S; Peakman M; Todd JA; Wicker LS; Tree TI
    J Immunol; 2012 May; 188(9):4644-53. PubMed ID: 22461703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD26: a negative selection marker for human Treg cells.
    Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M
    Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.
    Cabrera R; Ararat M; Xu Y; Brusko T; Wasserfall C; Atkinson MA; Chang LJ; Liu C; Nelson DR
    Cancer Immunol Immunother; 2013 Apr; 62(4):737-46. PubMed ID: 23223899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased regulatory function of CD4
    Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
    Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
    Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
    Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
    Wang R; Huang K
    Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn's disease.
    Khalili A; Ebrahimpour S; Maleki I; Abediankenari S; Afrouzi MM
    Rom J Intern Med; 2018 Sep; 56(3):158-166. PubMed ID: 29453928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
    Liberal R; Grant CR; Holder BS; Cardone J; Martinez-Llordella M; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2015 Sep; 62(3):863-75. PubMed ID: 25953611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
    Boschetti G; Nancey S; Sardi F; Roblin X; Flourié B; Kaiserlian D
    Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.
    Thorborn G; Pomeroy L; Isohanni H; Perry M; Peters B; Vyakarnam A
    PLoS One; 2010 Feb; 5(2):e9254. PubMed ID: 20174666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
    Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
    Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.